Pharmacokinetics and tissue disposition of a chimeric oligodeoxynucleoside phosphorothioate in rats after intravenous administration

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 2, 1996, Pages 971-979

  Zhang, Ruiwen ^a,b   Iyer, Radhakrishnan P ^c   Yu, Dong ^c   Tan, Weitian ^c   Zhang, Xueshu ^a   Lu, Zhihong ^a   Zhao, Hui ^a   Agrawal, Sudhir ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c HYBRIDON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHIMERA; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG FECES LEVEL; DRUG URINE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ANIMALS; BASE SEQUENCE; ELECTROPHORESIS; KIDNEY; LIVER; MOLECULAR SEQUENCE DATA; MYOCARDIUM; RATS; THIONUCLEOTIDES; TISSUE DISTRIBUTION;

EID: 0030426849     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. AGRAWAL, S.: Antisense oligonucleotides as antiviral agents. Trends Biotechnol. 10: 152-158, 1992.
2. AGRAWAL, S. AND GOODCHILD, J.: Oligodeoxynucleotide methylphosphonate: Synthesis and enzyme degradation. Tetrahedron Lett. 28: 3539-3542, 1987.
3. AGRAWAL, S., GOODCHILD, J., CIVIERA, M. P., THORTON, A. H., SARIN, P. S. AND ZAMECNIK, P. C.: Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 85: 7079-7083, 1988.
4. AGRAWAL, S. AND IYER, R. P.: Modified oligonucleotides as therapeutic and diagnostic agents. Curr. Opin. Biotechnol. 6: 112-119, 1995.
5. AGRAWAL, S., MAYRAND, S., ZAMECNIK, P. C. AND PEDERSON, T.: Site specific excision from RNA by RNase H and mixed phosphate backbone oligodeoxynucleotides. Proc. Natl. Acad. Sci. U.S.A. 87: 1401-1405, 1990.
6. AGRAWAL, S. AND TANG, J. Y.: GEM 91: An antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS. Antisense Res. Dev. 2: 261-266, 1992.
7. AGRAWAL, S. AND TANG, J. Y.: Self-stabilized antisense oligodeoxynucleotide phosphorothioates: Properties and anti-HIV activity. Nucleic Acids Res. 21: 27-35, 1993.
8. AGRAWAL, S., TEMSAMANI, J. AND TANG, J. Y.: Pharmacokinetics, biodistribution and stability of oligodeoxynucleotide phosphorothioates in mice. Proc. Natl. Acad. Sci. U.S.A. 88: 7595-7599, 1991.
9. AGRAWAL, S., TEMSAMANI, J., GALBRAITH, W. AND TANG, J. Y.: Pharmacokinetics of antisense oligonucleotides. Clin. Pharm. 28: 7-16, 1995a.
10. AGRAWAL, S., TEMSAMANI, J. AND TANG, J. Y.: Self-stabilized oligonucleotides as novel antisense agents. In Delivery Strategies: Antisense Oligonucleotide Therapeutics, ed. by S. Akhtar, pp. 105-121, CRC Press, New York, 1995b.
11. AGRAWAL, S., ZHANG, X., ZHAO, H., LU, Z., YAN, J., CAI, H., DIASIO, R. B., HABUS, I., JIANG, Z., IYER, R. P., YU, D. AND ZHANG, R.: Absorption, tissue distribution and in vivo stability in rats of a hybrid antisenae oligonucleotide following oral administration. Biochem. Pharmacol. 50: 571-576, 1995c.
12. AGRAWAL, S., RUSTOGI, P. K. AND SHAW, D. R.: Novel enzymatic and immunological responses to oligonucleotides. Toxicol. Lett. 83: 431-434, 1995d.
13. BAYEVER, E., IVERSON, P. L., BISHOP, M. R., SHARP, J. G., TEWARY, H. K., ARNESON, M. A., PIRRUCCELLO, S. J., RUDDON, R. W., KESSINGER, A., ZON, G. AND ARMITAGE, O.: Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: Initial results of a phase 1 trial. Antisense Res. Dev. 3: 383-390, 1993.
14. CHEN, T. L., MILLER, P. S., Ts'O, P. O. P. AND COLVIN, O. M.: Disposition and metabolism of oligodeoxynucleoside methylphosphonate following a single IV injection in mice. Drug Metab. Dispos. 18: 815-518, 1990.
15. 14C-labeled phosphorothioate oligonucleotide ISIS 2105, after intravenous administration to rats. J. Pharmacol. Exp. Ther. 267: 1181-1190, 1993.
16. 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intradermal administration to rats. J. Pharmacol. Exp. Ther. 269: 89-94, 1994.
17. 14C-labeled afovirsen sodium in patients with genital warts. Clin. Pharmacol. Ther. 56: 641-646, 1994.
18. ECKSTEIN, F.: A dinucleoside phosphorothioate. Tetrahedron Lett. 8: 1157-1160, 1967.
19. GALBRAITH, W. M., HOBSON, W. C., GICLAS, P. C., SCHECHTER, P. I. AND AGRAWAL, S.: Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey. Antisense Res. Dev. 4: 201-206, 1994.
20. IVERSON, P. L.: In vivo studies with phosphorothioate oligonucleotides: Rationale for systemic therapy. In Antisense Research and Applications, ed. by S. T. Crooke and B. Lebleu, pp. 461-469, CRC Press, Boca Raton, FL, 1993.
21. IVERSON, P., MATA, J., THACEWELL, W. G. AND ZON, G.: Pharmacokinetics of an antisense phosphorothioate oligodeoxynucleotide against rev from human immunodeficiency virus type 1 in the adult male rat following single injections and continuous infusion. Antisense Res. Dev. 4: 43-52, 1994.
22. METELEV, V., LISZIEWICZ, J. AND AGRAWAL, S.: Study of antisense oligonucleotide phosphorothioates containing segments of oligodeoxynucleotides and 2′-O-methyloligoribonucleotides. Bioorg. Med. Chem. Lett. 4: 2929-2934, 1994.
23. PADMAPRIYA, A. P., TANG, J. Y. AND AGRAWAL, S.: Large-scale synthesis, purification and analysis of oligodeoxynucleotide phosphorothioates. Antisense Res. Dev. 4: 185-199, 1994.
24. 3H-labeled oligonucleotides: Comparison of a phosphodiester and a phosphorothioate. Mol. Pharmacol. 45: 932-943, 1994.
25. SARIN, P. S., AGRAWAL, S., CIVIERA, M. P., GOODCHILD, J., IKEUCHI, T. AND ZAMECNIK, P. C.: Inhibition of acquired immunodeficiency syndrome virus by oligonucleoside methylphosphonates. Proc. Natl. Acad. Sci. U.S.A. 85: 7448-7451, 1988.
26. SARMIENTO, U. M., FEREZ, J. R., BECKER, J. M. AND NARAYANAN, R.: In vivo toxicological effects of rel A antisense phoephorothioates in CD-1 mice. Antisense Res. Dev. 4: 99-107, 1994.
27. TEMSAMANI, J., TANG, J. Y., PADMAPRIYA, A., KUBERT, M. AND AGRAWAL, S.: Pharmacokinetics, biodistribution, and stability of capped oligonucleotide phosphorothioates in mice. Antisense Res. Dev. 3: 277-284, 1993.
28. Ts'O, P. O. P.: Nonionic oligonucleotide analogues (Matagen) as anticodic agents in duplex and triplex formation. Antisense Res. Dev. 1: 273-283, 1991.
29. UHLMANN, E. AND PEYMAN, A.: Antisense oligonucleotide: A new therapeutic principle. Chem. Rev. 90: 544-584, 1990.
30. ZAMECNIK, P. C.: Oligonucleotide base hybridization as a modulator of genetic message readout. In Prospects for Antisense Nucleic Therapy of Cancer and AIDS, ed. by E. Wickstrom, pp. 1-6, Wiley Liss, New York, 1991.
31. ZHANG, R., YAN, J., SHAHINIAN, H., AMIN, G., LU, Z., LIU, T., SAAG, M. S., JIANG, Z., TEMSAMANI, J., MARTIN, R. R., SCHECHTER, P., AGRAWAL, S. AND DIASIO, R. B.: Pharmacokinetks of an oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects. Clin. Pharmacol. Ther. 58: 44-53, 1995a.
32. ZHANG, R., DIASIO, R. B., LU, Z., LIU, T. P., JIANG, Z., GALBRAITH, W. AND AGRAWAL, S.: Pharmacokinetks and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1. Biochem. Pharmacol. 49: 929-939, 1995b.
33. ZHANG, R., LU, Z., ZHANG, X., ZHAO, H., DIASIO, R. B., LIU, T., JIANG, Z. AND AGRAWAL, S.: In vivo stability and disposition of a self-stabilized oligodeoxynucleotide phosphorothioate in rats. Clin. Chem. 41: 836-843, 1995c.
34. ZHANG, R., LU, Z., ZHAO, X., DIASIO, R. B., HABUS, I., IYER, R. P., YU, D. AND AGRAWAL, S.: In vivo stability, disposition and metabolism of a 'hybrid' oligonucleotide phosphorothioate in rats. Biochem. Pharmacol. 50: 545-556, 1995d.
35. ZHAO, Q., TEMSAMANI, J., IADAROLA, P. L., JIANG, Z. AND AGRAWAL, S.: Effect of different modified oligodeoxynucleotides on immune stimulation. Biochem. Pharmacol. 51: 173-182, 1996.